Weiyuan Wei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 10%
Papers in
-
- Circular RNAs in diseases 3
- Oncology 8
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Yubo Xie (11 shared papers)Qiang Xiao (7 shared papers)Wenlong Cao (8 shared papers)Lin‐Hai Yan (6 shared papers)Qiang Xiao (5 shared papers)Zhenyong Tang (2 shared papers)Lei Li (2 shared papers)Yuntian Tang (1 shared paper)
- Journals
- OncoTargets and Therapy (3 papers)BioMed Research International (2 papers)Oncology Reports (2 papers)Scientific Reports (2 papers)BMJ Open (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiyuan Wei
21 papers receiving 438 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 163
- Geriatrics and Gerontology 23
- Oncology 124
- Molecular Biology 220
- Pathology and Forensic Medicine 39
Countries citing papers authored by Weiyuan Wei
This map shows the geographic impact of Weiyuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyuan Wei more than expected).
Fields of papers citing papers by Weiyuan Wei
This network shows the impact of papers produced by Weiyuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyuan Wei. The network helps show where Weiyuan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyuan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 61 | |
| 2 | 2014 | 41 | |
| 3 | 2018 | 41 | |
| 4 | 2016 | 36 | |
| 5 | 2017 | 34 | |
| 6 | 2012 | 27 | |
| 7 | 2020 | 26 | |
| 8 | 2013 | 25 | |
| 9 | 2019 | 21 | |
| 10 | Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance. | 2015 | 21 |
| 11 | 2015 | 18 | |
| 12 | 2022 | 15 | |
| 13 | 2015 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2020 | 11 | |
| 16 | 2014 | 11 | |
| 17 | 2020 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2024 | 6 | |
| 20 | 2024 | 5 |
About Weiyuan Wei
Weiyuan Wei is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 445 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (3 papers), Circular RNAs in diseases (3 papers), Digestive system and related health (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer-related molecular mechanisms research (3 papers), Colorectal Cancer Screening and Detection (2 papers) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (163 citations), Geriatrics and Gerontology (23 citations), Oncology (124 citations), Molecular Biology (220 citations) and Pathology and Forensic Medicine (39 citations). Weiyuan Wei has collaborated with scholars based in China and United States. Frequent co-authors include Yubo Xie, Qiang Xiao, Wenlong Cao, Lin‐Hai Yan, Qiang Xiao, Zhenyong Tang, Lei Li, Yuntian Tang, Wen Luo and Xiaoshi Zhang. Their work appears in journals such as OncoTargets and Therapy, BioMed Research International, Oncology Reports, Scientific Reports and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.